PCSK6 and pancreatic neoplasm: The results that single clones of both SUIT-2 and MIA PaCa-2 showed lower proliferation rates and fewer colony formation counts compared to controls, indicated that the inactivation of PCSK6 could inhibit the growth of tumor cells in pancreatic cancer.